MA Pharmacy Practice Resources & Guidance

Massachusetts: 90-day Supply for Certain Schedule II/III Prescriptions

The Massachusetts Board of Registration in Pharmacy updated its policy to allow a 90-day supply for certain Schedule II and III prescriptions, including those for opioid use disorder treatment, non-opioid stimulants, testosterone, and implantable infusion pumps. Other Schedule II and III medications remain limited to a 30-day supply.

MA Board Adopts Rapid Microbial Methods for Sterility Testing

The Massachusetts Board of Registration in Pharmacy has adopted a new policy allowing the use of Rapid Microbial Methods (RMMs) as an alternative for sterility release testing of compounded sterile preparations (CSPs). This policy outlines requirements for licensed sterile compounding pharmacies to ensure public safety when using these advanced technologies.

Rapid Microbial Methods Sterility Testing Guidance

The Massachusetts Department of Public Health has issued guidance on the use of Rapid Microbial Methods (RMMs) for sterility testing. This document outlines acceptable approaches and considerations for implementing RMMs in pharmaceutical and medical device manufacturing.

Massachusetts Pharmacy Practice Definitions

The Massachusetts Board of Registration in Pharmacy has issued a document defining key terms related to pharmacy practice. This guidance aims to clarify terminology for pharmacists and related entities operating within the state.

Pharmacy Policy: Definitions for Automated Dispensing, Compounding, and Events

The Massachusetts Board of Registration in Pharmacy has adopted Policy 2025-02, defining key terms related to automated dispensing devices, automated pharmacy systems, pharmacy processing automation, quality-related events, and serious adverse drug events. These definitions clarify regulatory expectations for pharmacies operating in the state.